87 related articles for article (PubMed ID: 21264841)
1. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients.
Armstrong TS; Vera-Bolanos E; Gning I; Acquaye A; Gilbert MR; Cleeland C; Mendoza T
Cancer; 2011 Jul; 117(14):3222-8. PubMed ID: 21264841
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of the MDASI-BT in patients with brain metastases.
Armstrong TS; Gning I; Mendoza TR; Weinberg JS; Gilbert MR; Tortorice ML; Cleeland CS
J Pain Symptom Manage; 2009 Mar; 37(3):331-40. PubMed ID: 18676120
[TBL] [Abstract][Full Text] [Related]
3. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT).
Armstrong TS; Mendoza T; Gning I; Coco C; Cohen MZ; Eriksen L; Hsu MA; Gilbert MR; Cleeland C
J Neurooncol; 2006 Oct; 80(1):27-35. PubMed ID: 16598415
[TBL] [Abstract][Full Text] [Related]
4. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for fatigue severity in primary brain tumor patients.
Armstrong TS; Cron SG; Bolanos EV; Gilbert MR; Kang DH
Cancer; 2010 Jun; 116(11):2707-15. PubMed ID: 20235192
[TBL] [Abstract][Full Text] [Related]
7. Congruence of primary brain tumor patient and caregiver symptom report.
Armstrong TS; Wefel JS; Gning I; Acquaye A; Vera-Bolanos E; Gilbert MR; Cleeland CS; Mendoza T
Cancer; 2012 Oct; 118(20):5026-37. PubMed ID: 22415423
[TBL] [Abstract][Full Text] [Related]
8. [Glioblastomas: clinical study and search for prognostic factors].
Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
[TBL] [Abstract][Full Text] [Related]
9. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.
Nejmi M; Wang XS; Mendoza TR; Gning I; Cleeland CS
J Pain Symptom Manage; 2010 Jul; 40(1):75-86. PubMed ID: 20619213
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma multiforme-report of 267 cases treated at a single institution.
Stark AM; Nabavi A; Mehdorn HM; Blömer U
Surg Neurol; 2005 Feb; 63(2):162-9; discussion 169. PubMed ID: 15680662
[TBL] [Abstract][Full Text] [Related]
11. Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module.
Tanaka S; Sato I; Takahashi M; Armstrong TS; Cleeland CS; Mendoza TR; Mukasa A; Takayanagi S; Narita Y; Kamibeppu K; Saito N
Jpn J Clin Oncol; 2020 Jul; 50(7):787-793. PubMed ID: 32280995
[TBL] [Abstract][Full Text] [Related]
12. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme.
Helseth R; Helseth E; Johannesen TB; Langberg CW; Lote K; Rønning P; Scheie D; Vik A; Meling TR
Acta Neurol Scand; 2010 Sep; 122(3):159-67. PubMed ID: 20298491
[TBL] [Abstract][Full Text] [Related]
13. The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.
Armstrong TS; Vera-Bolanos E; Acquaye AA; Gilbert MR; Ladha H; Mendoza T
Neuro Oncol; 2016 Feb; 18(2):252-60. PubMed ID: 26289592
[TBL] [Abstract][Full Text] [Related]
14. Uncertainty, mood states, and symptom distress in patients with primary brain tumors: analysis of a conceptual model using structural equation modeling.
Lin L; Chiang HH; Acquaye AA; Vera-Bolanos E; Gilbert MR; Armstrong TS
Cancer; 2013 Aug; 119(15):2796-806. PubMed ID: 23661311
[TBL] [Abstract][Full Text] [Related]
15. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
[TBL] [Abstract][Full Text] [Related]
16. A multicentre prospective collection of newly diagnosed glioblastoma patients in Lombardia, Italy.
Salmaggi A; Riva M; Silvani A; Merli R; Tomei G; Lorusso L; Russo A; Marchioni E; Imbesi F;
Neurol Sci; 2005 Oct; 26(4):227-34. PubMed ID: 16193249
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density is a prognostic indicator for patients with astroglial brain tumors.
Leon SP; Folkerth RD; Black PM
Cancer; 1996 Jan; 77(2):362-72. PubMed ID: 8625246
[TBL] [Abstract][Full Text] [Related]
18. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients.
Wang XS; Laudico AV; Guo H; Mendoza TR; Matsuda ML; Yosuico VD; Fragante EP; Cleeland CS
J Pain Symptom Manage; 2006 Jun; 31(6):542-52. PubMed ID: 16793494
[TBL] [Abstract][Full Text] [Related]
19. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory.
Ivanova MO; Ionova TI; Kalyadina SA; Uspenskaya OS; Kishtovich AV; Guo H; Mendoza TR; Novik A; Cleeland CS; Wang XS
J Pain Symptom Manage; 2005 Nov; 30(5):443-53. PubMed ID: 16310618
[TBL] [Abstract][Full Text] [Related]
20. Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC.
Stark AM; Stepper W; Mehdorn HM
Eur J Cancer Care (Engl); 2010 Jan; 19(1):39-44. PubMed ID: 19912295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
